Welcome to our dedicated page for DENTSPLY SIRONA news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on DENTSPLY SIRONA stock.
DENTSPLY SIRONA Inc. (symbol: XRAY) stands as the world’s largest manufacturer of professional dental products and technologies. As a global total solutions provider, Dentsply Sirona empowers dental professionals to offer better, safer, and faster dental care. The company’s extensive portfolio includes leading positions in consumables, equipment, technology, and specialty products. Dentsply Sirona is committed to innovation and quality, reflected in its comprehensive end-to-end solutions offering, which spans well-known and established brands in the industry.
Dentsply Sirona emerged from a merger between Dentsply International and Sirona Dental Systems in 2016. Today, the company manufactures and markets a complete range of dental and oral health products, including dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation.
Recently, Dentsply Sirona has announced enhancements to its DS Core platform, a cloud-based solution supporting dental professionals throughout the entire treatment continuum. The platform now boasts improved patient communication tools, a unified ordering system, and support for additional data formats, making it easier for dental practices to collaborate with labs and service providers.
Financially, Dentsply Sirona maintains a robust presence in the dental industry, with significant revenue generated through third-party distributors and direct sales to labs, offices, and consumers. The company’s ongoing commitment to innovation is further demonstrated by its DS World Las Vegas event, an annual gathering that provides dental professionals with market-leading education, networking opportunities, and exposure to the latest dental technologies.
With its headquarters in Charlotte, North Carolina, Dentsply Sirona continues to shape the future of dentistry, striving to enhance patient care and advance dental practices through its unwavering dedication to quality and innovation. For more information on Dentsply Sirona and its products, visit the official website.
Dentsply Sirona introduces a revamped Implants business, launching DS Implants that integrates brands like Simplant and MIS. The initiative presents three digital workflows designed to enhance implantology practices: Single Tooth, Partial Multiple Tooth Replacement, and Full Arch Signature Workflows, which aim to boost efficiency and patient satisfaction. A highlight is the DS PrimeTaper, a self-tapping implant with a tapered design for easier insertion and long-term bone stability. The company emphasizes a global clinical education program to support digital implant skills development among clinicians.
Dentsply Sirona (Nasdaq: XRAY) announced its annual clinical education event, Dentsply Sirona World (DS World) 2021, scheduled for September 23-25, 2021. This event will offer over 100 training programs and new product launches, featuring prominent speakers like Drs. Shivi Gupta and Dan Butterman. The hybrid format allows participants to join onsite in Las Vegas or virtually. Investors can access live webcasts of key sessions, including a dedicated investment community session on September 23.
Dentsply Sirona (Nasdaq: XRAY), a leading dental solutions provider, will participate in the Baird 2021 Global Healthcare Conference. CFO Jorge Gomez is scheduled for a fireside chat on September 15 at 2:35 PM ET. Investors can access a live webcast through the Investor section of the Dentsply Sirona website. A replay will also be available after the event. Established as a major manufacturer of dental products, Dentsply Sirona focuses on innovative solutions to enhance patient care and dentistry quality.
DENTSPLY SIRONA (XRAY) reported second-quarter 2021 revenues of $1,067 million, a substantial 117.3% increase from $491 million in Q2 2020. GAAP EPS stood at $0.45 compared to a loss of ($0.44) in 2020, while Non-GAAP EPS rose to $0.71 from a loss of ($0.18). Operating income also improved significantly, reaching $155 million from a loss of ($104 million). The company reaffirmed its FY21 Non-GAAP EPS outlook at $2.75 to $2.90 amidst a recovering dental market.
Dentsply Sirona announced an investor conference call on August 5, 2021, at 8:30 am ET to review its financial results. The call will be accessible via a live webcast on the Company’s investor website. Participants can dial +1-877-370-7637 for domestic calls or +1-629-228-0723 internationally, using conference ID # 4184820. A replay will be available for one week post-call. Dentsply Sirona is the world's largest manufacturer of dental products, and its stock is traded on Nasdaq under the symbol XRAY.
Dentsply Sirona (Nasdaq: XRAY) has acquired Propel Orthodontics for $131 million in cash. The acquisition includes Propel's VPro device and the Fastrack Mobile App, enhancing Dentsply's position in the growing clear aligner market. Propel Orthodontics is recognized for its innovative orthodontic devices and offers solutions for both in-office and at-home use. This strategic move aims to complement Dentsply's existing Byte® and SureSmile® businesses, reinforcing its commitment to advancing patient care in dentistry.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) has announced a 10% increase in its quarterly dividend, raising it from $0.10 to $0.11 per share. The new dividend will be paid on July 9, 2021 to shareholders on record by June 25, 2021. This decision reflects the company’s ongoing commitment to provide value to its investors while maintaining its standing as a leading manufacturer of dental products.
Dentsply Sirona (Nasdaq: XRAY) will participate in four investor conferences in June 2021. Key events include:
- William Blair 41st Annual Growth Stock Conference on June 2 at 9:40am ET
- Stifel 2021 Virtual Jaws & Paws Conference on June 3 at 10:00am ET
- Goldman Sachs 42nd Annual Global Healthcare Conference on June 9 at 9:40am ET
- Baird 2021 Healthcare ESG Symposium on June 17 at 10:40am ET
Live webcasts can be accessed through the Dentsply Sirona website, with replays available afterward.
Dentsply Sirona (Nasdaq: XRAY) reported strong first quarter 2021 results with revenue of $1,027 million, a 17.5% increase from $874 million in Q1 2020. GAAP EPS rose to $0.53 compared to a loss of ($0.63) last year. Non-GAAP EPS increased 67.4% to $0.72. Operating income also improved, reaching $154 million versus a loss of ($125 million) in 2020. The company raised its FY21 Non-GAAP EPS outlook to $2.75 to $2.90, reflecting optimism about the dental market recovery.
FAQ
What is the current stock price of DENTSPLY SIRONA (XRAY)?
What is the market cap of DENTSPLY SIRONA (XRAY)?
What does Dentsply Sirona Inc. do?
What is DS Core?
When was Dentsply Sirona formed?
Where is Dentsply Sirona headquartered?
What event does Dentsply Sirona host annually?
How can I learn more about Dentsply Sirona's products?
What kind of products does Dentsply Sirona offer?
What is the significance of Dentsply Sirona in the dental industry?
How does Dentsply Sirona distribute its products?
What recent updates has Dentsply Sirona announced?
